1. Home
  2. NSTG

NSTG

NanoString Technologies Inc.

Logo NanoString Technologies Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

0

NanoString Technologies Inc is engaged in the development, manufacturing and commercialization of instruments, consumables, and services for efficiently profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. Its core technology includes proprietary chemistries that enable the labeling and counting of single molecules. The firm uses its technology to develop tools for scientific and clinical research, primarily in the fields of genomics and proteomics. It offers two product platforms such as nCounter Analysis System or nCounter, and GeoMx Digital Spatial Profiler or DSP system both include instruments, related consumables, and software. NanoString Technologies generates revenue from the sale of products and related services and collaborations.

Founded: 2003 Country:
United States
United States
Employees: N/A City: SEATTLE
Market Cap: 8.1M IPO Year: 2013
Target Price: $2.83 AVG Volume (30 days): 18.3M
Analyst Decision: Buy Number of Analysts: 6
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.53 EPS Growth: N/A
52 Week Low/High: $0.05 - $11.78 Next Earning Date: 02-27-2024
Revenue: $162,473,000 Revenue Growth: 20.09%
Revenue Growth (this year): 41.72% Revenue Growth (next year): 13.78%

Share on Social Networks: